Pages that link to "Q33622570"

The following pages link to GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche. (Q33622570):

Displaying 50 items.

• Dinosaurs and ancient civilizations: reflections on the treatment of cancer (Q24628746) (← links)
• Bone metastases: When and how lung cancer interacts with bone (Q26823287) (← links)
• AXL kinase as a novel target for cancer therapy (Q26863442) (← links)
• Prostate cancer and parasitism of the bone hematopoietic stem cell niche (Q26996231) (← links)
• Mechanisms of disseminated cancer cell dormancy: an awakening field (Q27027015) (← links)
• Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G1 Arrest/S Phase Delay and Inhibition of Apoptosis During Chemotherapy in Bone Marrow (Q27853382) (← links)
• The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy (Q27928010) (← links)
• Cancer Cell Colonisation in the Bone Microenvironment (Q28072561) (← links)
• Tumor cell dormancy (Q28073065) (← links)
• Targeting the TAM Receptors in Leukemia (Q28078654) (← links)
• Initial steps of metastasis: cell invasion and endothelial transmigration (Q28238397) (← links)
• Single cell transcriptomic analysis of prostate cancer cells (Q30537663) (← links)
• Meta-analysis of microarray data identifies GAS6 expression as an independent predictor of poor survival in ovarian cancer (Q30656824) (← links)
• Molecular pathways: niches in metastatic dormancy (Q33838536) (← links)
• Bone-targeting agents in prostate cancer (Q33864723) (← links)
• Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells (Q34273700) (← links)
• Axl as a mediator of cellular growth and survival (Q34619118) (← links)
• GAS6 receptor status is associated with dormancy and bone metastatic tumor formation (Q34700694) (← links)
• IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma (Q34728942) (← links)
• Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodeling (Q35036800) (← links)
• Inactivation of GSK3β and activation of NF-κB pathway via Axl represents an important mediator of tumorigenesis in esophageal squamous cell carcinoma. (Q35125173) (← links)
• The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma (Q35149569) (← links)
• The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches (Q35499809) (← links)
• Homing of cancer cells to the bone (Q35603135) (← links)
• Bone marrow as a metastatic niche for disseminated tumor cells from solid tumors (Q35632622) (← links)
• The interconnectedness of cancer cell signaling (Q35669733) (← links)
• Mechanisms of cancer cell metastasis to the bone: a multistep process (Q35673417) (← links)
• TAM receptor signaling in immune homeostasis (Q35819380) (← links)
• Disseminated prostate cancer cells can instruct hematopoietic stem and progenitor cells to regulate bone phenotype (Q35840465) (← links)
• Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer (Q36044487) (← links)
• Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironment. (Q36062163) (← links)
• Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer (Q36298306) (← links)
• Current and emerging therapies for bone metastatic castration-resistant prostate cancer (Q36358303) (← links)
• Structure and function of the solid tumor niche (Q36676448) (← links)
• The prostate cancer bone marrow niche: more than just 'fertile soil'. (Q36700788) (← links)
• Metastasis prevention by targeting the dormant niche (Q36829245) (← links)
• Cancer to bone: a fatal attraction (Q36884628) (← links)
• Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow (Q37295465) (← links)
• The role of hematopoietic stem cell niche in prostate cancer bone metastasis (Q37337502) (← links)
• Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow (Q37397455) (← links)
• The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer (Q37520184) (← links)
• Imaging Axl expression in pancreatic and prostate cancer xenografts (Q37571724) (← links)
• The receptor AXL diversifies EGFR signaling and limits the response to EGFR-targeted inhibitors in triple-negative breast cancer cells (Q37627397) (← links)
• AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer (Q37684598) (← links)
• Expression of Axl and its prognostic significance in human breast cancer (Q37701037) (← links)
• TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling. (Q37735525) (← links)
• Molecular insights of Gas6/TAM in cancer development and therapy. (Q37745358) (← links)
• Targeting Tyrosine Kinases and Autophagy in Prostate Cancer (Q37847052) (← links)
• The metastatic niche and stromal progression (Q38018809) (← links)
• The receptor tyrosine kinase Axl in cancer: biological functions and therapeutic implications. (Q38104686) (← links)